PCOS Hair Loss: Why It Happens & How to Treat It

What Is PCOS — and Why Does It Cause Hair Loss?

Polycystic ovary syndrome (PCOS) is the most common endocrine disorder in reproductive-age women, estimated by the World Health Organization to affect 10–13% of women globally, with up to 70% remaining undiagnosed. The condition is characterized by androgen excess, irregular or absent ovulation, and — in many but not all cases — multiple small cysts on the ovaries. Hair loss is one of its most distressing external manifestations.

The link between PCOS and hair loss runs through androgens. In PCOS, the ovaries (and in some cases the adrenal glands) produce excess testosterone and androstenedione. Insulin resistance, which affects a substantial proportion of people with PCOS, further amplifies androgen production by suppressing sex hormone-binding globulin (SHBG) — the protein that binds and inactivates testosterone in circulation. The result is elevated free testosterone, which 5-alpha reductase enzymes convert to dihydrotestosterone (DHT) in target tissues, including scalp follicles.

In individuals with genetically sensitive scalp follicles — a susceptibility inherited independently of PCOS — DHT shortens the anagen (growth) phase, prolongs telogen (rest), and progressively miniaturizes the hair shaft. Over time, thick terminal hairs are replaced by finer, shorter vellus-like hairs, and eventually by empty follicles. This is androgenetic alopecia — the same process that causes male-pattern baldness, driven in women by PCOS-generated androgen excess rather than inherently high androgen levels.

What PCOS Hair Loss Looks Like

PCOS hair loss follows a female-pattern distribution — it does not produce the sharp M-shaped receding hairline typical of men. Instead, look for:

• Diffuse crown thinning: The top of the scalp thins, often appearing most pronounced along the central part.
• Widening part line: The gap between hairs at the parting gradually broadens.
• Temporal thinning: Some women also notice thinning at the temples.
• Maintained frontal hairline: Unlike male-pattern baldness, the frontal hairline is usually preserved.

A key diagnostic clue is the co-occurrence of opposing hair changes: scalp thinning alongside increased facial or body hair (hirsutism). When a woman develops a widening part and notices new chin, upper lip, or chest hair simultaneously, PCOS should be high on the differential.

How PCOS Hair Loss Differs From Other Causes

Hair loss in women has multiple causes, and distinguishing PCOS-driven androgenetic alopecia from other types guides treatment:

Telogen effluvium can co-exist with PCOS hair loss and may accelerate apparent shedding during metabolic stress. Female-pattern hair loss and PCOS hair loss are mechanistically the same process; PCOS is the hormonal context that drives it in younger women.

Diagnosis: What Tests to Request

PCOS hair loss should not be self-diagnosed. A thorough evaluation involves:

Clinical Assessment

• Hair loss pattern (Ludwig scale or Sinclair scale for female pattern)
• Signs of hyperandrogenism: hirsutism score (Ferriman-Gallwey), acne, scalp seborrhea
• Menstrual history and regularity

Blood Tests

• Total and free testosterone (liquid chromatography/mass spectrometry is the most accurate method)
• DHEAS (dehydroepiandrosterone sulfate) — screens for adrenal androgen excess
• Sex hormone-binding globulin (SHBG) — low SHBG increases free androgen availability
• Fasting insulin and glucose / HbA1c — assesses insulin resistance
• LH:FSH ratio — often elevated in PCOS
• TSH — excludes thyroid-driven hair loss
• Serum ferritin — excludes iron deficiency as a co-driver
• Prolactin — excludes hyperprolactinemia

Imaging

• Pelvic ultrasound to assess ovarian morphology (≥ 12 follicles per ovary, or ovarian volume > 10 mL)

Rotterdam criteria require at least two of three: clinical or biochemical hyperandrogenism; oligoovulation or anovulation; polycystic ovarian morphology on ultrasound. The Journal of Clinical Endocrinology & Metabolism consensus report notes that studies document FPHL prevalence of 20–30% in PCOS versus 8.8% in age-matched controls.

Treatment: A Two-Track Approach

PCOS hair loss has two independently addressable components: the underlying hormonal disorder and the hair follicle miniaturization it drives. The most effective approach treats both simultaneously.

Track 1 — Treating the Underlying PCOS

Combined Oral Contraceptives (COCs) COCs reduce ovarian androgen production and increase SHBG, binding more free testosterone. For hair loss, formulations containing low-androgenic progestins are essential — drospirenone (Yaz, Yasmin), norgestimate, or cyproterone acetate (where available). Levonorgestrel and norethisterone have androgenic activity and may worsen hair loss. COCs typically require 6–12 months to produce visible hair improvement.

Metformin For women with insulin resistance (confirmed by elevated fasting insulin, HbA1c, or impaired glucose tolerance), metformin reduces insulin levels, which in turn lowers androgen production. It is not a direct hair treatment but addresses a key upstream driver.

Lifestyle Modification Weight loss of 5–10% of body weight in overweight women with PCOS can substantially reduce androgen levels and improve hair and menstrual outcomes. This works partly through improved insulin sensitivity and reduced conversion of androgens in adipose tissue.

Track 2 — Treating the Hair Loss Directly

Topical Minoxidil (5%) Minoxidil is the first-line, FDA-approved topical treatment for female-pattern hair loss. It prolongs the anagen phase and increases follicular blood supply independently of the hormonal mechanism — making it effective regardless of the underlying androgen driver. Apply 1 mL of 5% solution (or the foam equivalent) once daily to dry scalp. Results require at least 6 months to assess; treatment is ongoing (hair returns to baseline if stopped).

Spironolactone (Oral) Spironolactone is an aldosterone antagonist with potent anti-androgen activity — it competes with DHT at the androgen receptor and inhibits 5-alpha reductase. It is the most widely used anti-androgen for female hair loss in the US. A 2023 systematic review and meta-analysis found:

• Overall improvement in 56.60% of treated women
• Combined spironolactone + minoxidil improved 65.80% of patients versus 43.21% for spironolactone alone
• Doses typically 80–200 mg/day; most studies used 100–200 mg/day

Spironolactone requires reliable contraception (it can feminize a male fetus) and potassium monitoring. Menstrual irregularity is a common side effect; it is often co-prescribed with a COC.

Finasteride Finasteride (2.5–5 mg/day in women; 1 mg is the male dose) inhibits 5-alpha reductase, blocking conversion of testosterone to DHT. It is used off-label in women and is absolutely contraindicated in pregnancy (causes genital abnormalities in male fetuses). Women on finasteride must use reliable contraception. Some evidence suggests efficacy comparable to spironolactone; combination with minoxidil enhances results.

Oral Minoxidil (Low-Dose) Low-dose oral minoxidil (0.25–1.25 mg/day for women) is increasingly used as an alternative or adjunct to topical minoxidil. A 2025 PMC review of minoxidil formulations confirmed systemic absorption with oral dosing provides more consistent follicular stimulation; side effects include hypertrichosis (unwanted facial hair) in some women — an ironic concern in PCOS where this is already present.

How Long Before You See Results?

PCOS hair loss treatment demands patience. A realistic timeline:

• 1–3 months: Shedding may initially increase slightly (especially with minoxidil, as telogen hairs are shed to make way for new anagen hairs)
• 3–6 months: Shedding stabilizes; fine baby regrowth may become noticeable
• 6–12 months: Visible improvement in density and hair diameter for responders
• 12+ months: Optimal results; anti-androgens (spironolactone, finasteride) typically show peak effect at 12–18 months

The Endocrinology/JAAD consensus recommends 12 months of treatment before evaluating full response.

When to See a Professional

See a dermatologist and/or gynecologist or endocrinologist if:

• You notice progressive hair thinning on the crown combined with irregular periods, acne, or unwanted facial/body hair
• Hair loss began before age 40 with no obvious trigger
• You have a known PCOS diagnosis and your hair loss is worsening despite oral contraceptive use
• You are considering finasteride or spironolactone (prescription required; monitoring needed)
• Hair loss is affecting mental health or quality of life significantly

PCOS hair loss rarely reverses completely, but with the right dual-track treatment it consistently stabilizes and often meaningfully improves. Early treatment preserves more follicles. Do not wait.